Harrow, Inc.
Current role
HROW
Bridseida Cruz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bridseida Cruz
Harrow, Inc. reported in an 8-K filed October 6, 2025 that Bridseida Cruz was appointed Head of Quality of ImprimisRx, effective October 6, 2025.
“Frank Mullery has been appointed as Chief Executive Officer and Bridseida Cruz has been appointed as Head of Quality of ImprimisRx.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Harrow, Inc. (HROW)
SEC 8-K
Current2025-10-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harrow, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis W. Mullery CEO
- Frank Mullery CEO
- John P. Saharek CEO
- Mark L. Baum CEO
- Robert J. Kammer Chairman
- Andrew Boll CFO
- Andrew R. Boll CFO
- Randall E. Pollard Chief Accounting Officer
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.